Kiniksa Pharmaceuticals International, plc (KNSA)

Healthcare Model Divergence low healthy

$77.91

Updated: 2026-09-05

TradeApes Score

Financial Strength

89 Strong

Operating Trend

96 Strong

Relative Value

38 Overvalued

Capital Allocation

37 Weak

Risk Management

80 Strong

Sector Rank #6

The market price implies growth our normalized base can't support, so we don't publish a single fair-value figure for KNSA.

Key Findings

+ operating-margin trend + inflection

Unlock Full Report →

− ev_to_ebitda vs sector peers

Unlock Full Report →

Industry Related Stocks

ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG) Aardvark Therapeutics, Inc. (AARD) Abivax S.A. (AAVXF) Ascend Wellness Holdings, Inc. (AAWH) AbbVie Inc. (ABBV) AbCellera Biologics Inc. (ABCL)

See all Healthcare stocks →

Get KNSA and 3,000+ stocks in your pocket

Health scores, fair-value estimates, and full company analysis — free on iPhone.

Download iPhone App

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.